Spleen-resident CD4 + and CD4 - CD8α - dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Bialecki, Emilie ^a,b,c,d,e   Fernandez, Elodie Macho ^a,b,c,d,e   Ivanov, Stoyan ^a,b,c,d,e   Paget, Christophe ^a,b,c,d,e   Fontaine, Josette ^a,b,c,d,e   Rodriguez, Fabien ^a,b,c,d,e   Lebeau, Luc ^f   Ehret, Christophe ^f   Frisch, Benoit ^f   Trottein, François ^a,b,c,d,e   Faveeuw, Christelle ^a,b,c,d,e  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c CNRS   (France)

^d INSERM   (France)

^e Institut Federatif de Recherche 142   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; INTERLEUKIN 12; T LYMPHOCYTE RECEPTOR; ALPHA-GALACTOSYLCERAMIDE; CD8 ANTIGEN; CD8ALPHA ANTIGEN; GALACTOSYLCERAMIDE;

ANIMAL CELL; ARTICLE; CD4+ DENDRITIC CELL; CD4+ T LYMPHOCYTE; CD4- CD8ALPHA- DENDRITIC CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; SPLEEN; STEADY STATE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CROSS PRESENTATION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL;

ANIMALS; ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; GALACTOSYLCERAMIDES; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; SPLEEN;

EID: 80055106651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026919     Document Type: Article

References (49)

1. Villadangos JA, Schnorrer P, (2007) Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7: 543-555.
2. Coquerelle C, Moser M, (2010) DC subsets in positive and negative regulation of immunity. Immunol Rev 234: 317-334.
3. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
4. Cohen NR, Garg S, Brenner MB, (2009) Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity. Adv Immunol 102: 1-94.
5. Godfrey DI, Kronenberg M, (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114: 1379-1388.
6. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H, (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21: 483-513.
7. Van Kaer L, Joyce S, (2005) Innate immunity: NKT cells in the spotlight. Curr Biol 15: R429-431.
8. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
9. Cerundolo V, Silk JD, Masri SH, Salio M, (2009) Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 9: 28-38.
10. Tupin E, Kinjo Y, Kronenberg M, (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5: 405-417.
11. Shortman K, Naik SH, (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30.
12. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K, (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164: 2978-2986.
13. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, et al. (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
14. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, et al. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199: 9-26.
15. Maldonado-Lopez R, De Smedt T, Michel P, Godfroid J, Pajak B, et al. (1999) CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189: 587-592.
16. Shortman K, Heath WR, (2010) The CD8+ dendritic cell subset. Immunol Rev 234: 18-31.
17. Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, et al. (2009) Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol 183: 7732-7742.
18. Qiu CH, Miyake Y, Kaise H, Kitamura H, Ohara O, et al. (2009) Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 182: 4127-4136.
19. Edwards AD, Chaussabel D, Tomlinson S, Schulz O, Sher A, et al. (2003) Relationships among murine CD11c(high) dendritic cell subsets as revealed by baseline gene expression patterns. J Immunol 171: 47-60.
20. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, et al. (2010) Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32: 279-289.
21. Henri S, Curtis J, Hochrein H, Vremec D, Shortman K, et al. (2002) Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production. Infect Immun 70: 3874-3880.
22. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, et al. (2001) Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166: 5448-5455.
23. Maroof A, Kaye PM, (2008) Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. Infect Immun 76: 239-249.
24. Proietto AI, O'Keeffe M, Gartlan K, Wright MD, Shortman K, et al. (2004) Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 209: 163-172.
25. Manickasingham SP, Edwards AD, Schulz O, Reis e Sousa C, (2003) The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur J Immunol 33: 101-107.
26. Bezbradica JS, Stanic AK, Matsuki N, Bour-Jordan H, Bluestone JA, et al. (2005) Distinct roles of dendritic cells and B cells in Vα14Jα18 natural T cell activation in vivo. J Immunol 174: 4696-4705.
27. Chang DH, Osman K, Connolly J, Kukreja A, Krasovsky J, et al. (2005) Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med 201: 1503-1517.
28. Fujii S, Shimizu K, Kronenberg M, Steinman RM, (2002) Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 3: 867-874.
29. Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, et al. (2004) Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103: 383-389.
30. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, et al. (2005) Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115: 2572-2583.
31. Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Sakamori R, et al. (2007) Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor. Hepatology 45: 22-30.
32. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, et al. (1999) Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol 163: 2387-2391.
33. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, et al. (2001) Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 166: 6012-6018.
34. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, et al. (1999) The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189: 1121-1128.
35. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
36. Simkins HM, Hyde E, Farrand KJ, Ong ML, Degli-Esposti MA, et al. (2010) Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo. J Leukoc Biol.
37. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, et al. (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189: 103-110.
38. Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, et al. (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664-667.
39. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, et al. (2000) CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13: 453-462.
40. Seder RA, Gazzinelli R, Sher A, Paul WE, (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 90: 10188-10192.
41. Baev DV, Caielli S, Ronchi F, Coccia M, Facciotti F, et al. (2008) Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice. J Immunol 181: 869-877.
42. Leite-De-Moraes MC, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, et al. (2001) IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol 166: 945-951.
43. Matsumoto G, Kubota E, Omi Y, Lee U, Penninger JM, (2004) Essential role of LFA-1 in activating Th2-like responses by alpha-galactosylceramide-activated NKT cells. J Immunol 173: 4976-4984.
44. Uchida T, Kinoshita M, Fukasawa M, Habu Y, Shinomiya N, et al. (2007) IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells. Eur J Immunol 37: 966-977.
45. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, et al. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
46. Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, et al. (2008) Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol 1: 208-218.
47. Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, et al. (2009) Role of marginal zone B lymphocytes in invariant NKT cell activation. J Immunol 182: 6105-6113.
48. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
49. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, et al. (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863-865.